Miguel Ángel Araque Caballero

<scp>sTREM</scp> 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero et al. · EMBO Molecular Medicine · 2016 · 503 citations · Full text

Immunology, Neurochemical Biomarkers, Social Sciences +20

Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer’s disease

Michael Ewers, Nicolai Franzmeier, Marc Suárez‐Calvet et al. · Science Translational Medicine · 2019 · 315 citations · Full text

Early changes in CSF sTREM2 in dominantly inherited Alzheimer’s disease occur after amyloid deposition and neuronal injury

Marc Suárez‐Calvet, Miguel Ángel Araque Caballero, Gernot Kleinberger et al. · Science Translational Medicine · 2016 · 272 citations · Full text

Early Changes, Csf Strem2 Increase, Immunology +19

White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease

Miguel Ángel Araque Caballero, Marc Suárez‐Calvet, Marco Duering et al. · Brain · 2018 · 175 citations · Full text

Left frontal hub connectivity delays cognitive impairment in autosomal-dominant and sporadic Alzheimer’s disease

Nicolai Franzmeier, Emrah Düzel, Frank Jessen et al. · Brain · 2018 · 119 citations · Full text

Neuropsychology, Brain Function, Frontal Cortex Connectivity +20